603207 小方制药
已收盘 12-17 15:00:00
资讯
新帖
简况
小方制药:12月9日召开业绩说明会
证券之星 · 12-09
小方制药:12月9日召开业绩说明会
小方制药(603207)披露召开2025年第三季度业绩说明会公告,12月1日股价上涨0.34%
证券之星 · 12-01
小方制药(603207)披露召开2025年第三季度业绩说明会公告,12月1日股价上涨0.34%
小方制药(603207)11月20日股东户数1.41万户,较上期增加2.58%
证券之星 · 11-21
小方制药(603207)11月20日股东户数1.41万户,较上期增加2.58%
每周股票复盘:小方制药(603207)取消监事会并更换审计机构
证券之星 · 11-16
每周股票复盘:小方制药(603207)取消监事会并更换审计机构
小方制药(603207)披露更换持续督导保荐代表人公告,11月14日股价下跌0.5%
证券之星 · 11-14
小方制药(603207)披露更换持续督导保荐代表人公告,11月14日股价下跌0.5%
小方制药(603207)披露关于控股子公司参与竞拍土地使用权的议案,11月10日股价下跌0.4%
证券之星 · 11-10
小方制药(603207)披露关于控股子公司参与竞拍土地使用权的议案,11月10日股价下跌0.4%
每周股票复盘:小方制药(603207)拟取消监事会并更换审计机构
证券之星 · 11-09
每周股票复盘:小方制药(603207)拟取消监事会并更换审计机构
小方制药新注册《制药企业ERP-MES与污水在线监控一体化智能管理平台V1.0》项目的软件著作权
证券之星 · 11-08
小方制药新注册《制药企业ERP-MES与污水在线监控一体化智能管理平台V1.0》项目的软件著作权
小方制药(603207)披露拟取消监事会并变更审计机构,11月04日股价下跌1.1%
证券之星 · 11-04
小方制药(603207)披露拟取消监事会并变更审计机构,11月04日股价下跌1.1%
小方制药:2025年10月31日公司股东人数是13364户
证券日报 · 11-04
小方制药:2025年10月31日公司股东人数是13364户
每周股票复盘:小方制药(603207)股东户数降至1.33万户
证券之星 · 11-02
每周股票复盘:小方制药(603207)股东户数降至1.33万户
股市必读:小方制药(603207)股东户数1.34万户,较上期减少1.02%
证券之星 · 10-27
股市必读:小方制药(603207)股东户数1.34万户,较上期减少1.02%
每周股票复盘:小方制药(603207)Q3净利增5.09%,股东户数减少
证券之星 · 10-26
每周股票复盘:小方制药(603207)Q3净利增5.09%,股东户数减少
小方制药:10月10日高管蒋昶增持股份合计500股
证券之星 · 10-20
小方制药:10月10日高管蒋昶增持股份合计500股
每周股票复盘:小方制药(603207)拟每股派现0.70元(含税)
证券之星 · 10-12
每周股票复盘:小方制药(603207)拟每股派现0.70元(含税)
小方制药闲置募集资金现金管理产品全部到期赎回
中金财经 · 10-11
小方制药闲置募集资金现金管理产品全部到期赎回
小方制药(603207)披露2025年半年度权益分派实施公告,10月10日股价下跌0.3%
证券之星 · 10-10
小方制药(603207)披露2025年半年度权益分派实施公告,10月10日股价下跌0.3%
小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)
智通财经 · 09-25
小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)
每周股票复盘:小方制药(603207)布局创新药并拓展境外市场
证券之星 · 09-14
每周股票复盘:小方制药(603207)布局创新药并拓展境外市场
小方制药:9月12日召开业绩说明会
证券之星 · 09-12
小方制药:9月12日召开业绩说明会
加载更多
公司概况
公司名称:
上海小方制药股份有限公司
所属行业:
医药制造业
上市日期:
2024-08-26
主营业务:
上海小方制药股份有限公司的主营业务是外用药的研发、生产和销售。公司的主要产品是开塞露、甘油灌肠剂、炉甘石洗剂、氧化锌软膏、水杨酸软膏、硫软膏、解痉镇痛酊、冻疮膏、复方薄荷脑软膏、尿素维E乳膏、硼酸洗液、苯扎溴铵溶液、苯扎溴铵酊、复方醋酸地塞米松乳膏、复方苦参水杨酸散、白花油、酮康唑乳膏、复方土槿皮酊。
发行价格:
12.47
{"stockData":{"symbol":"603207","market":"SH","secType":"STK","nameCN":"小方制药","latestPrice":28.09,"timestamp":1765954800000,"preClose":27.96,"halted":0,"volume":704400,"delay":0,"changeRate":0.0046,"floatShares":54400000,"shares":161000000,"eps":1.3297,"marketStatus":"已收盘","change":0.13,"latestTime":"12-17 15:00:00","open":27.96,"high":28.18,"low":27.73,"amount":19720400,"amplitude":0.0161,"askPrice":28.11,"askSize":20,"bidPrice":28.09,"bidSize":27,"shortable":0,"etf":0,"ttmEps":1.3297,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":27.96,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":30.76,"lowLimit":25.16,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":160559967,"isCdr":false,"pbRate":4.28,"roa":"--","peRate":21.125066,"roe":"14.15%","epsLYR":1.53,"committee":0.844444,"marketValue":4510000000,"turnoverRate":0.0129,"status":0,"floatMarketCap":1528000000},"requestUrl":"/m/hq/s/603207","defaultTab":"news","newsList":[{"id":"2590312648","title":"小方制药:12月9日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2590312648","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590312648?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:02","pubTimestamp":1765274535,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年12月9日小方制药发布公告称公司于2025年12月9日召开业绩说明会。公司于2025年12月9日召开2025年第三季度业绩说明会,交流情况可登陆上海证券交易所上证路演中心查阅。小方制药主营业务:外用药的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900028555.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2588776645","title":"小方制药(603207)披露召开2025年第三季度业绩说明会公告,12月1日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588776645","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588776645?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:52","pubTimestamp":1764600739,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘,小方制药报收于29.41元,较前一交易日上涨0.34%,最新总市值为47.22亿元。该股当日开盘29.28元,最高29.51元,最低29.27元,成交额达1742.8万元,换手率为1.09%。公司近日发布公告称,上海小方制药股份有限公司将于2025年12月09日11:00-12:00通过上证路演中心网络互动方式召开2025年第三季度业绩说明会,介绍公司2025年第三季度经营成果及财务状况。投资者可于2025年12月2日至12月8日16:00前通过上证路演中心网站或公司邮箱提交问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100037842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2585111804","title":"小方制药(603207)11月20日股东户数1.41万户,较上期增加2.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585111804","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585111804?lang=zh_cn&edition=full","pubTime":"2025-11-21 18:12","pubTimestamp":1763719948,"startTime":"0","endTime":"0","summary":"证券之星消息,近日小方制药披露,截至2025年11月20日公司股东户数为1.41万户,较11月10日增加355.0户,增幅为2.58%。在化学制药行业个股中,小方制药股东户数低于行业平均水平,截至11月20日,化学制药行业平均股东户数为3.44万户。从股价来看,2025年11月10日至2025年11月20日,小方制药区间跌幅为7.49%,在此期间股东户数增加355.0户,增幅为2.58%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100028437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2583651711","title":"每周股票复盘:小方制药(603207)取消监事会并更换审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2583651711","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583651711?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:03","pubTimestamp":1763236993,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,小方制药报收于31.58元,较上周的32.16元下跌1.8%。公司公告汇总关于上海小方制药股份有限公司2025年第二次临时股东大会的法律意见书本公司将于2025年10月25日召开临时股东大会,审议关于控股子公司参与竞拍土地使用权的议案。会议审议通过了关于取消监事会并修订《公司章程》的议案、修订多项公司治理制度的议案以及更换2025年度审计机构的议案。中小投资者对更换审计机构议案进行了单独计票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2583502728","title":"小方制药(603207)披露更换持续督导保荐代表人公告,11月14日股价下跌0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583502728","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583502728?lang=zh_cn&edition=full","pubTime":"2025-11-14 22:44","pubTimestamp":1763131460,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘,小方制药报收于31.58元,较前一交易日下跌0.5%,最新总市值为50.7亿元。该股当日开盘31.73元,最高31.94元,最低31.58元,成交额达4590.7万元,换手率为2.66%。近日,上海小方制药股份有限公司发布公告,因保荐代表人陈振瑜先生工作变动,不再担任公司持续督导保荐代表人,国信证券委派陈圣先生接替其职务。公司董事会对陈振瑜先生在任期间的贡献表示感谢。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400042075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2582877255","title":"小方制药(603207)披露关于控股子公司参与竞拍土地使用权的议案,11月10日股价下跌0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582877255","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582877255?lang=zh_cn&edition=full","pubTime":"2025-11-10 22:34","pubTimestamp":1762785266,"startTime":"0","endTime":"0","summary":"截至2025年11月10日收盘,小方制药报收于32.03元,较前一交易日下跌0.4%,最新总市值为51.43亿元。该股当日开盘32.16元,最高32.34元,最低31.96元,成交额达3479.84万元,换手率为1.99%。公司近日发布公告称,将于2025年10月25日召开2025年第二次临时股东大会,审议关于控股子公司参与竞拍土地使用权的议案。公司将对中小投资者单独计票并披露表决结果。本次竞拍事项构成关联交易,不构成重大资产重组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000034895.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2582380864","title":"每周股票复盘:小方制药(603207)拟取消监事会并更换审计机构","url":"https://stock-news.laohu8.com/highlight/detail?id=2582380864","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582380864?lang=zh_cn&edition=full","pubTime":"2025-11-09 04:40","pubTimestamp":1762634418,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘,小方制药报收于32.16元,较上周的32.35元下跌0.59%。本周,小方制药11月3日盘中最高价报33.1元。本周关注点公司公告汇总:小方制药拟取消监事会,相关职权由董事会审计委员会行使。公司公告汇总:公司拟将2025年度审计机构变更为德勤华永会计师事务所。公司公告汇总上海小方制药股份有限公司将于2025年11月10日召开第二次临时股东大会,审议三项议案。会议采取现场投票与网络投票相结合方式表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001676.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2581349833","title":"小方制药新注册《制药企业ERP-MES与污水在线监控一体化智能管理平台V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2581349833","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581349833?lang=zh_cn&edition=full","pubTime":"2025-11-08 02:00","pubTimestamp":1762538455,"startTime":"0","endTime":"0","summary":"证券之星消息,近日小方制药新注册了《制药企业ERP-MES与污水在线监控一体化智能管理平台V1.0》项目的软件著作权。今年以来小方制药新注册软件著作权2个。结合公司2025年中报财务数据,今年上半年公司在研发方面投入了482.46万元,同比减26.47%。通过天眼查大数据分析,上海小方制药股份有限公司共对外投资了2家企业,参与招投标项目2482次;财产线索方面有商标信息54条,专利信息134条,著作权信息10条;此外企业还拥有行政许可503个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110800000916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","01477","BK1574","603207","BK0239"],"gpt_icon":0},{"id":"2580375316","title":"小方制药(603207)披露拟取消监事会并变更审计机构,11月04日股价下跌1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580375316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580375316?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:45","pubTimestamp":1762267557,"startTime":"0","endTime":"0","summary":"截至2025年11月4日收盘,小方制药报收于32.42元,较前一交易日下跌1.1%,最新总市值为52.05亿元。其中,关于取消监事会并修订《公司章程》的议案受到市场关注。该议案拟取消公司监事会设置,原监事会职权由董事会审计委员会行使;同时,公司章程中“股东大会”统一调整为“股东会”,“监事会”或“监事”表述相应修改为“审计委员会”或“审计委员会成员”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110400039803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2580307407","title":"小方制药:2025年10月31日公司股东人数是13364户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580307407","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580307407?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:36","pubTimestamp":1762263360,"startTime":"0","endTime":"0","summary":"证券日报网讯小方制药11月4日在互动平台回答投资者提问时表示,2025年10月31日公司股东人数是13364户。(文章来源:证券日报)\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-04/doc-infwhekh9765149.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-04/doc-infwhekh9765149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2580405380","title":"每周股票复盘:小方制药(603207)股东户数降至1.33万户","url":"https://stock-news.laohu8.com/highlight/detail?id=2580405380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580405380?lang=zh_cn&edition=full","pubTime":"2025-11-02 10:11","pubTimestamp":1762049469,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,小方制药报收于32.35元,较上周的32.13元上涨0.68%。本周,小方制药10月27日盘中最高价报32.69元。10月31日盘中最低价报31.63元。小方制药当前最新总市值51.94亿元,在化学制药板块市值排名100/151,在两市A股市值排名3215/5163。股本股东变化:户均持股数量由上期的1.2万股上升至1.21万股,户均持股市值为38.9万元。股本股东变化股东户数变动截至2025年10月20日,公司股东户数为1.33万户,较9月30日减少33.0户,减幅0.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200002319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2578668105","title":"股市必读:小方制药(603207)股东户数1.34万户,较上期减少1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578668105","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578668105?lang=zh_cn&edition=full","pubTime":"2025-10-27 06:17","pubTimestamp":1761517031,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,小方制药报收于32.13元,上涨0.16%,换手率1.73%,成交量9421.0手,成交额3041.95万元。股本股东变化股东户数变动近日小方制药披露,截至2025年9月30日公司股东户数为1.34万户,较9月19日减少138.0户,减幅为1.02%。- 归属于上市公司股东的所有者权益:本报告期末1,054,095,400.88元,较年度末下降14.60%。公司公告汇总2025年第三季度报告报告期末普通股股东总数为13,356户,表决权恢复的优先股股东总数为0户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700001758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2578500451","title":"每周股票复盘:小方制药(603207)Q3净利增5.09%,股东户数减少","url":"https://stock-news.laohu8.com/highlight/detail?id=2578500451","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578500451?lang=zh_cn&edition=full","pubTime":"2025-10-26 04:40","pubTimestamp":1761424818,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘,小方制药报收于32.13元,较上周的33.48元下跌4.03%。股本股东变化高管增减持2025年10月10日,公司董事蒋昶增持公司股份500.0股,占公司总股本的0.0003%。当日公司股价收盘报33.59元,变动期间股价下跌0.3%。股东户数变动截至2025年9月30日,公司股东户数为1.34万户,较9月19日减少138户,减幅为1.02%。运佳远东有限公司持股58.59%,为第一大股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600001285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2576859051","title":"小方制药:10月10日高管蒋昶增持股份合计500股","url":"https://stock-news.laohu8.com/highlight/detail?id=2576859051","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576859051?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:13","pubTimestamp":1760962433,"startTime":"0","endTime":"0","summary":"证券之星消息,根据10月20日市场公开信息、上市公司公告及交易所披露数据整理,小方制药最新董监高及相关人员股份变动情况:2025年10月10日公司董事蒋昶共增持公司股份500.0股,占公司总股本为0.0003%。变动期间公司股价下跌0.3%,10月10日当日收盘报33.59元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000028728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2574680294","title":"每周股票复盘:小方制药(603207)拟每股派现0.70元(含税)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574680294","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574680294?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:40","pubTimestamp":1760211625,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,小方制药报收于33.59元,较上周的33.73元下跌0.42%。本周,小方制药10月9日盘中最高价报33.88元。本周关注点公司公告汇总:小方制药2025年半年度权益分派方案公布,每股派发现金红利0.70元(含税)。本次利润分配以公司总股本160,559,967股为基数,共派发现金红利112,391,976.90元。分配对象为截至股权登记日在中国结算上海分公司登记在册的全体A股股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2574481585","title":"小方制药闲置募集资金现金管理产品全部到期赎回","url":"https://stock-news.laohu8.com/highlight/detail?id=2574481585","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574481585?lang=zh_cn&edition=full","pubTime":"2025-10-11 08:29","pubTimestamp":1760142554,"startTime":"0","endTime":"0","summary":"中访网数据 上海小方制药股份有限公司发布公告,其使用闲置募集资金进行现金管理的相关产品已全部到期赎回,本金及收益均已归还至募集资金专户。公告披露了具体赎回情况,涉及上海浦东发展银行、中国工商银行和招商银行的多笔定期存款及通知存款产品,累计赎回本金达3.03亿元人民币,并获得相应投资收益。公司此前经董事会和监事会审议批准,使用不超过2亿元人民币的闲置募集资金进行现金管理,投资于安全性高、流动性好的银行存款类产品。截至公告日,公司使用闲置募集资金购买理财产品的余额为零,所有操作均在授权额度与期限内完成,未出现逾期情况。此举旨在提高募集资金使用效率,为公司及股东获取更多投资回报。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251011/31697771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","603207"],"gpt_icon":0},{"id":"2574170159","title":"小方制药(603207)披露2025年半年度权益分派实施公告,10月10日股价下跌0.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574170159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574170159?lang=zh_cn&edition=full","pubTime":"2025-10-10 22:55","pubTimestamp":1760108115,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,小方制药报收于33.59元,较前一交易日下跌0.3%,最新总市值为53.93亿元。公司近日发布《2025年半年度权益分派实施公告》,宣布本次利润分配方案为每股派发现金红利0.70元(含税)。股权登记日为2025年10月17日,除权(息)日和现金红利发放日均为2025年10月20日。本次权益分派以公司总股本160,559,967股为基数,合计派发现金红利112,391,976.90元。分配对象为截至股权登记日在中国证券登记结算有限责任公司上海分公司登记在册的全体A股股东。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101000039859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603207","BK0239"],"gpt_icon":0},{"id":"2570061090","title":"小方制药(603207.SH)委托博济医药技术开发中药1.1类新药“复方侧柏酊”(脱发适应症)","url":"https://stock-news.laohu8.com/highlight/detail?id=2570061090","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570061090?lang=zh_cn&edition=full","pubTime":"2025-09-25 16:13","pubTimestamp":1758787987,"startTime":"0","endTime":"0","summary":"智通财经APP讯,小方制药(603207.SH)发布公告,公司近日与博济医药科技股份有限公司(简称“博济医药”)签署了《技术委托(开发)合同》,博济医药将协助公司完成中药 1.1 类复方侧柏酊新药临床研究及注册,推动其完成临床试验及上市。本次公司与博济医药签署的《技术委托(开发)合同》,是双方基于共同发展战略的一次强强联合,标志着公司在创新药领域布局迈出重要一步。博济医药作为行业领先企业,在研发实力、技术积累和临床资源方面具有显著优势,双方合作将充分发挥各自专长,形成协同效应,有效提升合同产品的研发效率与成功率,为产品后续申报及上市奠定坚实基础。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BK0239","603207","300404"],"gpt_icon":0},{"id":"2567813692","title":"每周股票复盘:小方制药(603207)布局创新药并拓展境外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2567813692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567813692?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:58","pubTimestamp":1757797089,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘,小方制药报收于34.76元,较上周的34.69元上涨0.2%。本周,小方制药9月9日盘中最高价报36.96元。本周关注点来自机构调研要点:小方制药已开始布局创新药领域,多个项目处于不同研发阶段。来自机构调研要点:复方侧柏酊与复方透骨草溶液为公司研发的中药一类新药。公司目前已经取得了向中国澳门地区出口药品的批准文号并实现在中国澳门地区的销售,未来将逐步开拓其他境外市场。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","603207","BK0239","159992","BK1574","06978"],"gpt_icon":0},{"id":"2566978545","title":"小方制药:9月12日召开业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2566978545","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566978545?lang=zh_cn&edition=full","pubTime":"2025-09-12 18:03","pubTimestamp":1757671391,"startTime":"0","endTime":"0","summary":"证券之星消息,2025年9月12日小方制药发布公告称公司于2025年9月12日召开业绩说明会。公司目前已经取得了向中国澳门地区出口药品的批准文号并实现在中国澳门地区的销售,未来将逐步开拓其他境外市场。同时,公司会严格按照监管要求及时披露相关信息。问题3、请问方总,目前小方制药正在进行的创新药研发有哪些,谢谢!公司于2025年9月12日召开2025年半年度业绩说明会,交流情况可登陆上海证券交易所上证路演中心查阅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091200029436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603207"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765994240258,"stockEarnings":[{"period":"1week","weight":-0.0236},{"period":"1month","weight":-0.0817},{"period":"3month","weight":-0.1932},{"period":"6month","weight":0.0365},{"period":"1year","weight":0.1106},{"period":"ytd","weight":0.0731}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海小方制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14287人(较上一季度增加0.32%)","perCapita":"3807股","listingDate":"2024-08-26","address":"上海市奉贤区洪朱路777号","registeredCapital":"16055万元","survey":" 上海小方制药股份有限公司的主营业务是外用药的研发、生产和销售。公司的主要产品是开塞露、甘油灌肠剂、炉甘石洗剂、氧化锌软膏、水杨酸软膏、硫软膏、解痉镇痛酊、冻疮膏、复方薄荷脑软膏、尿素维E乳膏、硼酸洗液、苯扎溴铵溶液、苯扎溴铵酊、复方醋酸地塞米松乳膏、复方苦参水杨酸散、白花油、酮康唑乳膏、复方土槿皮酊。","listedPrice":12.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"小方制药(603207)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供小方制药(603207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"小方制药,603207,小方制药股票,小方制药股票老虎,小方制药股票老虎国际,小方制药行情,小方制药股票行情,小方制药股价,小方制药股市,小方制药股票价格,小方制药股票交易,小方制药股票购买,小方制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"小方制药(603207)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供小方制药(603207)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}